Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2387-2398

  Kalkunte, Satyan ^a   Boij, Roland ^b   Norris, Wendy ^a   Friedman, Jennifer ^a   Lai, Zhongbin ^a   Kurtis, Jonathan ^a   Lim, Kee Hak ^c   Padbury, James F ^a   Matthiesen, Leif ^d   Sharma, Surendra ^a  

^a BROWN UNIVERSITY   (United States)

^b Linkoping University Medical School   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CD135 ANTIGEN; ENDOGLIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD SAMPLING; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOTHELIUM CELL; FEMALE; FETUS; GESTATION PERIOD; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MATERNAL MORBIDITY; MOUSE; NONHUMAN; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYMPTOM; TISSUE INJURY; TROPHOBLAST;

EID: 78149324500     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100475     Document Type: Article

References (67)

1. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005, 365:785-799
2. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594
3. Ilekis JV, Reddy UM, Roberts JM: Preeclampsia- a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. J Reprod Sci 2007, 14:508-523
4. Noris M, Perico N, Remuzzi G: Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005, 1(2):98-114
5. Redman CWG, Sargent IL: Placental debris, oxidative stress and preeclampsia. Placenta 2000, 21:597-602
6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683
7. Roberts JM, Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56
8. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004, 200:957-965
9. Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S: Evolution of non-cytotoxic uterine natural killer cells. Am J Reprod Immunol 2008, 59:425-432
10. Redman CW: Immunological aspects of pre-eclampsia. Baillieres Clin Obstet Gynaecol 1992, 6:601-615
11. Roberts JM, Hubel CA: The two stage model of preeclampsia: variations on the theme. Placenta 2009, 23:S32-S37
12. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002, 160:1405-1423
13. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group: Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005
14. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA: A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008, 21:9-23
15. Solomon CG, Seely EW: Preeclampsia: searching for the cause. N Engl J Med 2004, 350:641-642
16. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945-952
17. Herse F, Staff AC, Hering L, Müller DN, Luft FC, Dechend R: AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med 2008, 86:697-703
18. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y: Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008, 14:855-862
19. Parikh SM, Karumanchi SA: Putting pressure on pre-eclampsia. Nat Med 2008, 14:810-812
20. Rossant J, Cross JC: Placental development: lessons from mouse mutants. Nat Rev Genet 2001, 2:538-548
21. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R: Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008, 453:1117-1121
22. Hayakawa S, Fujikawa T, Fukuoka H, Chisima F, Karasaki-Suzuki M, Ohkoshi E, Ohi H, Kiyoshi Fujii T, Tochigi M, Satoh K, Shimizu T, Nishinarita S, Nemoto N, Sakurai I: Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation. J Reprod Immunol 2000, 47:121-138
23. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996, 274:995-998
24. Kanayama N, Takahashi K, Matsuura T, Sugimura M, Kobayashi T, Moniwa N, Tomita M, Nakayama K: Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 2002, 8:1129-1135
25. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss RM, Bates JN: Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002, 39:337-342
26. Podjarny E, Losonczy G, Baylis C: Animal models of preeclampsia. Semin Nephrol 2004, 24:596-606
27. Falcao S, Solomon C, Monat C, Bérubé J, Gutkowska J, Lavoie JL: Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice. Am J Physiol Heart Circ Physiol 2009, 296:H119-H126
28. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S: Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000, 164:5721-5728
29. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S: Evidence for interleukin-10-mediated inhibition of cyclooxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006, 55:19-27
30. Plevyak M, Hanna N, Mayer S, Murphy S, Pinar H, Fast L, Ekerfelt C, Ernerudh J, Berg G, Matthiesen L, Sharma S: Deficiency of decidual IL-10 in first trimester missed abortion: a lack of correlation with the decidual immune cell profile. Am J Reprod Immunol 2002, 47: 242-250
31. Robertson SA, Skinner RJ, Care AS: Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006, 177:4888-4896
32. Murphy SP, Hanna NN, Fast LD, Shaw SK, Berg G, Padbury JF, Romero R, Sharma S: Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol 2009, 200:308, e1-9
33. Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009, 183:1144-1154
34. Tewari N, Kalkunte S, Murray DW, Sharma S: The water channel aquaporin 1 is a novel molecular target of polychlorinated biphenyls for in utero anomalies. J Biol Chem 2009, 284:15224-15232
35. Hennessy A, Pilmore HL, Simmons LA, Painter DM: A deficiency of placental IL-10 in preeclampsia. J Immunol 1999, 163:3491-3495
36. Makris A, Xu B, Yu B, Thornton C, Hennessy A: Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 2006, 27:445-451
37. Ashkar AA, Di Santo JP, Croy BA: Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000, 192:259-269
38. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006, 12:1065-1074
39. Moffett A, Loke C: Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006, 6:584-594
40. Burton GJ, Woods AW, Jauniaux E, Kingdom JC: Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009, 30:473-482
41. Kalkunte S, Lai Z, Tewari N, Chichester C, Romero R, Padbury J, Sharma S: In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. Placenta 2008, 29:871-878
42. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet 2002, 77:67-75
43. Wedgbury K, Waller-Jones T: Measuring blood pressure using automated sphygmomanometer. Br J Nurs 2008, 17:714-718
44. Murphy SP, Fast LD, Hanna NN, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005, 175:4084-4090
45. Koch CJ, Evans SM, Lord EM: Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer 1995, 72:869-874
46. Koch CJ, Lord EM, Shapiro IM, Clyman RI, Evans SM: Imaging hypoxia and blood flow in normal tissues. Adv Exp Med Biol 1997, 428:585-593
47. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK: Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993, 206:204-211
48. Kalkunte S, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S: VEGF C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009, 182:4085-4092
49. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658
50. Schäffer L, Vogel J, Breymann C, Gassmann M, Marti HH: Preserved placental oxygenation and development during severe systemic hypoxia. Am J Physiol Regul Integr Comp Physiol 2006, 290:R844-R851
51. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649
52. Gaber LW, Spargo BH, Lindheimer MD: Renal pathology in preeclampsia. Baillieres Clin Obstet Gynaecol 1994, 8:443-468
53. Brosens I, Dixon HG, Robertson WB: Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977, 84:656-663
54. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A: A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994, 101:669-674
55. Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, Rotmensch S, Romero R: Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003, 189:1063-1069
56. Rampersad R, Barton A, Sadovsky Y, Nelson DM: The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta 2008, 29:855-861
57. Zhou CC, Ahmad S, Mi T, Abbasi S, Xia L, Day MC, Ramin SM, Ahmed A, Kellems RE, Xia Y: Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008, 51:1010-1019
58. Hung TH, Skepper JN, Charnock-Jones SD, Burton GJ: Hypoxia reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002, 90:1274-1281
59. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I: Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006, 291(4):R1085-1093
60. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M: Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta-3. J Clin Invest 2000, 105:577-587
61. Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N, Conrad KP: Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 2001, 64:499-506
62. Royle C, Lim S, Xu B, Tooher J, Ogle R, Hennessy A: Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants. Cytokine 2009, 47:56-60
63. Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y: Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Investig 2005, 12:428-432
64. Gu Y, Lewis DF, Wang Y: Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2008, 93:260-266
65. Xiong Y, Liebermann DA, Tront JS, Holtzman EJ, Huang Y, Hoffman B, Geifman-Holtzman O: Gadd45a stress signaling regulates sFlt-1 expression in preeclampsia. J Cell Physiol 2009, 220:632-639
66. Sharma S, Norris WE, Kalkunte S: Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia. J Reprod Immunol 2010, 85:112-116
67. Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boij R, Neubeck S, Markert UR, Sharma S: Novel approaches for mechanistic understanding and predicting preeclampsia. J Reprod Immunol 2009, 83:134-138